357P China lung cancer screening (CLUS) version 2.0: 5-year follow-up updates – Multimodal integration and novel techniques optimize lung cancer screening efficacy

3 1, 6, 3, 3 6, 12 12, 3 Total number of CTs 5 2 4 3 3 Positive bloodbased miRNA not available At surgery At baseline At baseline and surgery At baseline Postoperative UICC Stage IA2 IB IA1 IA1 IA1 *Time between scans. Conclusions:The data highlights the necessity of follow-up after initial indetermined CTs in Lung Cancer Screenings.It also highlights that this can take multiple years to adequately follow-up patients.miRNA profiling at baseline may be a promising option for risk-stratification as well as personalized follow-up intervals.